Oaktree Acquisition Corp. III Life Sciences OACC
NASDAQ OACC
$10.82 +0.07 (+0.65%)
At close: Aug 20, 2026 · 4:00 PM EDT

Oaktree Acquisition Corp. III Life Sciences (OACC) Enterprise Value (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences' (OACC) quarterly Enterprise Value came in at -$1.3 million in Q1 2026, little changed YoY from -$1.3 million in Q1 2025, and little changed on a QoQ basis from -$1.3 million in Q1 2025.

Oaktree Acquisition Corp. III Life Sciences (OACC) Enterprise Value (2025 - 2026) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences (OACC) has 2 years of Enterprise Value data on file, last reported at -$1.3 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - -816,134.00
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - -250,000.00
3 Drugs Made In America Acquisition 506.00 Mn 506.00 Mn - -174,974.00
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - -25,000.00
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - -10,586.00
6 Aldel Financial 397.49 Mn 397.49 Mn - -283,112.00
7 Pioneer Acquisition I 390.89 Mn 653.32 Mn - 262.44 Mn
8 Republic Digital Acquisition 389.25 Mn 388.51 Mn - -735,027.00
9 Gores Holdings X 385.06 Mn 384.87 Mn - -194,541.00
10 Oaktree Acquisition Corp. III Life Sciences 206.39 Mn 206.39 Mn - -1.18 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.18 Mn
Mar 31, 2026 -1.28 Mn
Mar 31, 2025 -1.28 Mn